Table I.

Gene set enrichment analysis

Pathways/signatures References Enriched in WT Enriched in Nfatc1−/− B cells Nominal P value FDRq value 
Cell cycle Brentani et al., 2003  Yes No <0.0001 <0.07 
 Cho et al., 2001      
 Whitfield et al., 2002      
 Liu et al., 2004      
Proliferation Shaffer et al., 2002  Yes No <0.0001 <0.09 
 Rosenwald et al., 2002      
 Su et al., 2004      
Myc targets Zeller et al., 2003  Yes No <0.01 <0.08 
 Yu et al., 2005      
Antiapoptosis Wu et al., 2002  Yes No ≤0.01 <0.08 
Wnt signaling Kenny et al., 2005  Yes No <0.031 0.24 
Pathways/signatures References Enriched in WT Enriched in Nfatc1−/− B cells Nominal P value FDRq value 
Cell cycle Brentani et al., 2003  Yes No <0.0001 <0.07 
 Cho et al., 2001      
 Whitfield et al., 2002      
 Liu et al., 2004      
Proliferation Shaffer et al., 2002  Yes No <0.0001 <0.09 
 Rosenwald et al., 2002      
 Su et al., 2004      
Myc targets Zeller et al., 2003  Yes No <0.01 <0.08 
 Yu et al., 2005      
Antiapoptosis Wu et al., 2002  Yes No ≤0.01 <0.08 
Wnt signaling Kenny et al., 2005  Yes No <0.031 0.24 

Gene set enrichment analysis (GSEA) of microarray data of splenic B cells from WT and mb1-cre x Nfatc1flx/flx mice stimulated for 16 h by α-IgM using 81 lymphoma-associated signatures from the signature database of the Staudt laboratory (http://lymphochip.nih.gov/signaturedb) and 1.687 curated gene sets (c2) from the Molecular Signatures Database (MSigDB; Subramanian et al., 2005). All references mentioned in Table I are cited in Subramanian et al., 2005.

or Create an Account

Close Modal
Close Modal